المؤلفون: Morabito F, Tripepi G, Martino EA, Vigna E, Mendicino F, Morabito L, Todoerti K, Al-Janazreh H, D’Arrigo G, Canale FA, Cutrona G, Neri A, Martino M, Gentile M

المصدر: Drug Design, Development and Therapy, Vol Volume 15, Pp 2969-2978 (2021)

مصطلحات موضوعية: multiple myeloma, relapsed resistant, melphalan flufenamide, melflufen, therapy, melphalan, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.dovepress.com/spotlight-on-melphalan-flufenamide-an-up-and-coming-therapy-for-the-tr-peer-reviewed-fulltext-article-DDDT; https://doaj.org/toc/1177-8881

URL الوصول: https://doaj.org/article/78112dfd1d7c4af6a1cfdd63706bc9e5

المؤلفون: Chiodin, G, Drennan, S, Martino, EA, Ondrisova, L, Henderson, I, del Rio, L, Tracy, I, D'Avola, A, Parker, H, Bonfiglio, S, Scarfo, L, Sutton, LA, Strefford, JC, Forster, J, Brake, O, Potter, KN, Sale, B, Lanham, S, Mraz, M, Ghia, P, Stevenson, FK, Forconi, F

المصدر: Blood advances. 6(18):5494-5504

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:151110807

المؤلفون: Chiodin, G, Dutton, D, Martino, EA, Drennan, S, Tracy, I, Ondrisova, L, Henderson, I, D'Avola, A, Pitsillidou, C, Mraz, M, Johnson, P, Duncombe, A, Packham, G, Steele, AJ, Parker, H, Bonfiglio, S, Scarfo, L, Sutton, LA, Ghia, P, Rose-Zerilli, MJJ, Strefford, JC, Stevenson, FK, Forconi, F

المصدر: BLOOD. 134

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:145390094

المؤلفون: Parrinello, N, Rizzo, G, Romano, A, Fiumara, P, Mauro, E, Pirosa, Mc, Martino, Ea, Giallongo, C, Tibullo, D, La Cava, P, Triolo, Am, DI RAIMONDO, Francesco

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______4731::044e4e27baf5faebb15b237050521ad2
http://hdl.handle.net/20.500.11769/44880

المؤلفون: Ernesto Vigna, Fortunato Morabito, Cirino Botta, Giovanni Martinelli, Francesco Mendicino, Enrica Antonia Martino, Concetta Conticello, Alessandra Romano, Massimo Gentile, Giuseppe Antonio Palumbo, Claudio Cerchione, Francesco Di Raimondo

المساهمون: Botta C, Martino EA, Conticello C, Mendicino F, Vigna E, Romano A, Palumbo GA, Cerchione C, Martinelli G, Morabito F, Di Raimondo F, Gentile M

المصدر: Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Opinion, lenalidomide, lcsh:RC254-282, chemistry.chemical_compound, Internal medicine, medicine, Lenalidomide, Isatuximab, carfilzomib, Bortezomib, business.industry, network meta analysis, bortezomib, Daratumumab, Refractory Multiple Myeloma, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, daratumumab, Carfilzomib, myeloma, chemistry, Meta-analysis, business, medicine.drug, isatuximab

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a437d9050d8933036080bb63322f924
https://pubmed.ncbi.nlm.nih.gov/33937048

المؤلفون: Matteo Pagnesi, Enrico Antonio Martino, Mauro Chiarito, Richard J. Jabbour, Antonio Colombo, Nicolas M. Van Mieghem, Antonio Mangieri, Cosmo Godino, Azeem Latib, Giovanni Landoni, Susheel Kodali

المساهمون: Cardiology, Pagnesi, M, Martino, Ea, Chiarito, M, Mangieri, A, Jabbour, Rj, Van Mieghem, Nm, Kodali, Sk, Godino, C, Landoni, Giovanni, Colombo, A, Latib, A.

المصدر: International Journal of Cardiology, 221, 97-106. Elsevier Ireland Ltd

مصطلحات موضوعية: medicine.medical_specialty, 030204 cardiovascular system & hematology, Embolic Protection Devices, Transcatheter Aortic Valve Replacement, 03 medical and health sciences, Postoperative Complications, 0302 clinical medicine, medicine, Humans, 030212 general & internal medicine, Prospective cohort study, Stroke, Cerebral injury, medicine.diagnostic_test, business.industry, Magnetic resonance imaging, Aortic Valve Stenosis, medicine.disease, Confidence interval, Diffusion Magnetic Resonance Imaging, Treatment Outcome, Aortic valve stenosis, Meta-analysis, Asymptomatic Diseases, Radiology, Cardiology and Cardiovascular Medicine, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb75cbd51063e04705fa506ad1dfface
https://doi.org/10.1016/j.ijcard.2016.06.143

المؤلفون: Pasquale Nardelli, Dario Winterton, G. Fanelli, Laura Pasin, Giovanni Landoni, Enrico Antonio Martino, Maria Grazia Calabrò, Alberto Zangrillo, Tiziana Bove

المساهمون: Martino, Ea, Winterton, D, Nardelli, P, Pasin, L, Calabrò, Mg, Bove, T, Fanelli, G, Zangrillo, Alberto, Landoni, Giovanni

مصطلحات موضوعية: medicine.medical_specialty, Serotonin reuptake inhibitor, coma, 030204 cardiovascular system & hematology, anesthesia, Serotonin syndrome, law.invention, 03 medical and health sciences, Postoperative Complications, 0302 clinical medicine, law, selective serotonin reuptake inhibitors, Intensive care, vasoplegic syndrome, Humans, Medicine, 030212 general & internal medicine, Cardiac Surgical Procedures, Vasoplegic syndrome, Aged, intensive care, Aged, 80 and over, Coma, serotonin syndrome, business.industry, anesthesia, coma, intensive care, methylene blue, selective serotonin reuptake inhibitors, serotonin syndrome, thoracic surgery, vasoplegic syndrome, Electroencephalography, medicine.disease, Intensive care unit, thoracic surgery, Surgery, Cardiac surgery, Anesthesiology and Pain Medicine, Cardiothoracic surgery, Anesthesia, methylene blue, Female, medicine.symptom, Cardiology and Cardiovascular Medicine, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ada0db5d0e3d1986e630ad4f0295e31a
http://hdl.handle.net/11390/1122950

المؤلفون: Martino EA; Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy., Palmieri S; Hematology Unit, Ospedale Cardarelli, Napoli, Italy., Galli M; Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni, Bergamo, Italy., Derudas D; Department of Hematology, Businco Hospital, Cagliari, Italy., Mina R; Division of Hematology, AOU Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy., Della Pepa R; Department of Clinical Medicine and Surgery, Hematology Unit, University of Naples 'Federico II', Naples, Italy., Zambello R; Department of Medicine, University of Padova, Hematology Unit, Padova, Italy.; Veneto Institute of Molecular Medicine, Padova, Italy., Vigna E; Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy., Bruzzese A; Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy., Mangiacavalli S; Division of Hematology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy., Zamagni E; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy., Califano C; Onco-Hematology Unit, 'A. Tortora' Hospital, Pagani, Italy., Musso M; Department of Oncology, Onco-Hematology Unit and TMO U.O.C., Palermo, Italy., Conticello C; Division of Hematology, Azienda Policlinico-S. Marco, University of Catania, Catania, Italy., Cerchione C; Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Mele G; Department of Hematology, Hospital Perrino, Brindisi, Italy., Di Renzo N; Department of Hematology, Hospital Vito Fazzi, Lecce, Italy., Offidani M; Hematology Unit, AOU delle Marche, Ancona, Italy., Tarantini G; Hematology Unit, 'Dimiccoli' Hospital, Barletta (BAT), Italy., Casaluci GM; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy., Rago A; UOSD Ematologia, Rome, Italy., Ria R; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Aldo Moro Medical School, Internal Medicine 'G. Baccelli'; CITEL, Bari, Italy.; Interdepartmental Centre for Research in Telemedicine, University of Bari Aldo Moro, Bari, Italy., Uccello G; Hematology Department, G. Garibaldi Hospital, Catania, Italy., Barilà G; Hematology Unit, Ospedale San Bortolo, Vicenza, Italy., Palumbo G; Department of Hematology, Hospital University Riuniti, Foggia, Italy., Pettine L; Hematology Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy., Vincelli ID; Department of Hemato-Oncology and Radiotherapy, Hematology Unit, Great Metropolitan Hospital 'Bianchi-Melacrino-Morelli', Reggio Calabria, Italy., Brunori M; Internal Medicine, Ospedale Santa Croce, Fano, Italy., Accardi F; Department of Hematology I, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy., Amico V; UOSD Ematologia, AORN San Pio, Benevento, Italy., Amendola A; Hematology Unit, Azienda Ospedaliera Regionale 'San Carlo', Potenza, Italy., Fontana R; Hematology and Transplant Center, University Hospital 'San Giovanni di Dio e Ruggi d'Aragona', Salerno, Italy., Bongarzoni V; Department of Hematology, San Giovanni-Addolorata Hospital, Rome, Italy., Rossini B; Hematology and Cell Therapy Unit, IRCCS Istituto Tumori 'Giovanni Paolo II' Bari, Bari, Italy., Cotzia E; Section of Hematology- Ospedale E. Muscatello-Augusta, Siracusa, Italy., Gozzetti A; Hematology, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena, Italy., Rizzi R; Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico Bari, Bari, Italy.; Department of Precision and Regenerative Medicine and Ionian Area, 'Aldo Moro' University School of Medicine, Bari, Italy., Sgherza N; Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico Bari, Bari, Italy., Reddiconto G; Department of Hematology, Hospital Vito Fazzi, Lecce, Italy., Maroccia A; Hematology Unit - Ospedale dell'Angelo Azienda ULSS n.3 Serenissima, Venezia Mestre, Italy., Franceschini L; Lymphoproliferative Diseases Unit, Tor Vergata University Hospital, Rome, Italy., Bertuglia G; Dipartimento di Oncologia ed Ematologia SC Ematologia 1 A.O. Citta' della Salute e della Scienza di Torino P.O. Molinette, Torino, Italy., Nappi D; Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Barbieri E; Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy., Gamberi B; Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy., Petrucci MT; Department of Translational and Precision Medicine, Hematology Azienda Policlinico Umberto I Sapienza University of Rome, Rome, Italy., Di Raimondo F; Division of Hematology, Azienda Policlinico-S. Marco, University of Catania, Catania, Italy., Neri A; Scientific Directorate, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy., Morabito F; Gruppo Amici Dell'Ematologia Foundation-GrADE, Reggio Emilia, Italy., Musto P; Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico Bari, Bari, Italy.; Department of Precision and Regenerative Medicine and Ionian Area, 'Aldo Moro' University School of Medicine, Bari, Italy., Gentile M; Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy.; Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende, Italy.

المصدر: Hematological oncology [Hematol Oncol] 2024 Jul; Vol. 42 (4), pp. e3290.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Multiple Myeloma*/mortality , Multiple Myeloma*/pathology , Dexamethasone*/administration & dosage , Dexamethasone*/adverse effects , Dexamethasone*/therapeutic use , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Thalidomide*/analogs & derivatives , Thalidomide*/administration & dosage , Thalidomide*/adverse effects , Thalidomide*/therapeutic use, Humans ; Male ; Female ; Aged ; Middle Aged ; Retrospective Studies ; Follow-Up Studies ; Aged, 80 and over ; Adult ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Drug Resistance, Neoplasm ; Survival Rate

المؤلفون: Bruzzese A; Department of Onco-hematology, Hematology Unit, A.O. of Cosenza, Cosenza, Italy., Martino EA; Department of Onco-hematology, Hematology Unit, A.O. of Cosenza, Cosenza, Italy., Mendicino F; Department of Onco-hematology, Hematology Unit, A.O. of Cosenza, Cosenza, Italy., Lucia E; Department of Onco-hematology, Hematology Unit, A.O. of Cosenza, Cosenza, Italy., Olivito V; Department of Onco-hematology, Hematology Unit, A.O. of Cosenza, Cosenza, Italy., Capodanno I; SOC Ematologia Azienda USL-IRCSS di Reggio Emilia, Reggio Emilia, Italy., Neri A; Scientific Direction Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy., Morabito F; Biotechnology Research Unit, Aprigliano, A.O./ASP of Cosenza, Cosenza, Italy., Vigna E; Department of Onco-hematology, Hematology Unit, A.O. of Cosenza, Cosenza, Italy., Gentile M; Department of Onco-hematology, Hematology Unit, A.O. of Cosenza, Cosenza, Italy.; Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende, Italy.

المصدر: European journal of haematology [Eur J Haematol] 2024 Jun; Vol. 112 (6), pp. 860-869. Date of Electronic Publication: 2024 Jan 31.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Myelodysplastic Syndromes*/genetics , Myelodysplastic Syndromes*/therapy , Myelodysplastic Syndromes*/diagnosis , Myelodysplastic Syndromes*/etiology , Chromosome Deletion* , Chromosomes, Human, Pair 5*/genetics, Humans ; Lenalidomide/therapeutic use ; Antineoplastic Agents/therapeutic use ; Antineoplastic Agents/pharmacology

المؤلفون: Palandri F; IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Istituto Di Ematologia 'Seràgnoli', Bologna, Italy. francesca.palandri@unibo.it., Auteri G; IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Istituto Di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento Di Medicina Specialistica, Diagnostica E Sperimentale, Università Di Bologna, Bologna, Italy., Abruzzese E; Hematology, S.Eugenio Hospital, Tor Vergata University, ASL Roma2, Rome, Italy., Caocci G; Hematology Unit, Department of Medical Sciences, University of Cagliari, Cagliari, Italy., Bonifacio M; Hematology and Bone Marrow Transplant Unit, Section of Biomedicine of Innovation, Department of Engineering for Innovative Medicine, University of Verona, Verona, Italy., Mendicino F; U.O.C. Di Ematologia, Department of Hemato-Oncology, Azienda Ospedaliera Annunziata, Cosenza, Italy., Latagliata R; Hematology Unit, Ospedale Belcolle, Viterbo, Italy., Iurlo A; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Branzanti F; Dipartimento Di Medicina Specialistica, Diagnostica E Sperimentale, Università Di Bologna, Bologna, Italy., Garibaldi B; Postgraduate School of Hematology, University of Catania, Catania, Italy., Trawinska MM; Hematology, S.Eugenio Hospital, Tor Vergata University, ASL Roma2, Rome, Italy., Cattaneo D; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Krampera M; Hematology and Bone Marrow Transplant Unit, Section of Biomedicine of Innovation, Department of Engineering for Innovative Medicine, University of Verona, Verona, Italy., Mulas O; Hematology Unit, Department of Medical Sciences, University of Cagliari, Cagliari, Italy., Martino EA; U.O.C. Di Ematologia, Department of Hemato-Oncology, Azienda Ospedaliera Annunziata, Cosenza, Italy., Cavo M; IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Istituto Di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento Di Medicina Specialistica, Diagnostica E Sperimentale, Università Di Bologna, Bologna, Italy., Vianelli N; IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Istituto Di Ematologia 'Seràgnoli', Bologna, Italy., Impera S; Department of Hematology, ARNAS Garibaldi, Catania, Italy., Efficace F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy., Heidel F; Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School (MHH), Hannover, Germany., Breccia M; Division of Cellular Biotechnologies and Hematology, University Sapienza, Rome, Italy., Elli EM; Divisione di Ematologia e Unità Trapianto di Midollo, Fondazione IRCCS San Gerardo Dei Tintori, Monza, Italy., Palumbo GA; Dipartimento di Scienze Mediche, Chirurgiche e Tecnologie Avanzate 'G.F. Ingrassia', Università Di Catania, Catania, Italy.

المصدر: Annals of hematology [Ann Hematol] 2024 Jun; Vol. 103 (6), pp. 1931-1940. Date of Electronic Publication: 2024 Mar 13.

نوع المنشور: Journal Article; Multicenter Study; Clinical Trial

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Primary Myelofibrosis*/drug therapy , Nitriles* , Pyrimidines*/therapeutic use , Pyrazoles*/therapeutic use , Polycythemia Vera*/drug therapy , Medication Adherence*/statistics & numerical data, Humans ; Male ; Female ; Prospective Studies ; Aged ; Middle Aged ; Italy/epidemiology ; Aged, 80 and over ; Adult